HUP0401914A2 - Eljárás piridil-alkilszulfonilpirazol-származékok előállítására - Google Patents

Eljárás piridil-alkilszulfonilpirazol-származékok előállítására

Info

Publication number
HUP0401914A2
HUP0401914A2 HU0401914A HUP0401914A HUP0401914A2 HU P0401914 A2 HUP0401914 A2 HU P0401914A2 HU 0401914 A HU0401914 A HU 0401914A HU P0401914 A HUP0401914 A HU P0401914A HU P0401914 A2 HUP0401914 A2 HU P0401914A2
Authority
HU
Hungary
Prior art keywords
alkyl
carbon atom
atom
pyridil
preparing
Prior art date
Application number
HU0401914A
Other languages
English (en)
Inventor
Denis Ernest Bourassa
Michael James Castaldi
David Harold Brown Ripin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HUP0401914A2 publication Critical patent/HUP0401914A2/hu
Publication of HUP0401914A3 publication Critical patent/HUP0401914A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A találmány (1) általános képletű vegyületek előállítására, valamintaz ilyen eljárásokban használható közbenső vegyületekre vonatkozik,ahol a képletben R1 jelentése fenilcsoport, amely adott esetben ahalogénatom, a hidroxil-, ciano-, merkapto-, 1-6 szénatomos alkil-, 2-6 szénatomos alkenil-, 1-6 szénatomos alkoxi-, -OCF3, 1-6 szénatomosalkil-S-, 1-6 szénatomos alkil-S(=O)-, 1-6 szénatomos alkil-SO2-,amino-, 1-6 szénatomos alkilamino-, di(1-6 szénatomos alkil)amino-,H2N-(C=O)-, (1-6 szénatomos alkil)NH-(C=O)- és formilcsoport közülegymástól függetlenül választott 1-3 csoporttal helyettesített; R2jelentése hidrogénatom, halogénatom vagy 1-6 szénatomos alkilcsoport;R3 jelentése 1-6 szénatomos alkilcsoport, amely adott esetben 1-3halogénatommal helyettesített; és R4 jelentése 1-6 szénatomosalkilcsoport. Ó
HU0401914A 2001-09-28 2002-09-19 Process for preparing pyridil-alkylsulfonyl pyrazole derivatives HUP0401914A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32564701P 2001-09-28 2001-09-28
PCT/IB2002/003908 WO2003029244A1 (en) 2001-09-28 2002-09-19 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives

Publications (2)

Publication Number Publication Date
HUP0401914A2 true HUP0401914A2 (hu) 2005-01-28
HUP0401914A3 HUP0401914A3 (en) 2006-04-28

Family

ID=23268786

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401914A HUP0401914A3 (en) 2001-09-28 2002-09-19 Process for preparing pyridil-alkylsulfonyl pyrazole derivatives

Country Status (20)

Country Link
US (2) US6646128B2 (hu)
EP (1) EP1430046A1 (hu)
JP (1) JP2005504127A (hu)
KR (1) KR20040039424A (hu)
CN (1) CN1561339A (hu)
AR (1) AR036680A1 (hu)
BR (1) BR0212860A (hu)
CA (1) CA2457798A1 (hu)
CZ (1) CZ2004414A3 (hu)
GT (1) GT200200183A (hu)
HU (1) HUP0401914A3 (hu)
IL (1) IL160369A0 (hu)
MX (1) MXPA04002879A (hu)
PA (1) PA8555601A1 (hu)
PE (1) PE20030532A1 (hu)
PL (1) PL370110A1 (hu)
RU (1) RU2004109148A (hu)
UY (1) UY27453A1 (hu)
WO (1) WO2003029244A1 (hu)
ZA (1) ZA200401043B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008534505A (ja) * 2005-03-25 2008-08-28 メルク エンド カムパニー インコーポレーテッド テストステロンサプリメントおよび5アルファ−レダクターゼインヒビターによる男性の治療方法
EA028642B1 (ru) * 2007-07-23 2017-12-29 Те Чайниз Юниверсити Ов Гонгконг Способ пренатальной диагностики фетальной хромосомной анэуплоидии

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
IL104311A (en) 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5434178A (en) 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
US5475018A (en) 1993-11-30 1995-12-12 G. D. Searle & Co. 1,5-diphenyl pyrazole compounds for treatment of inflammation
DK0923933T3 (da) 1993-11-30 2002-10-21 Searle & Co Substituerede pyrazolyl-benzensulfonamider til anvendelse ved behandling af inflammation
US5401765A (en) 1993-11-30 1995-03-28 G. D. Searle 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
CA2195847A1 (en) 1994-07-27 1996-02-08 John J. Talley Substituted thiazoles for the treatment of inflammation
US5620999A (en) 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5585504A (en) 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge
DE69529690T2 (de) 1994-12-21 2003-11-13 Merck Frosst Canada Inc Diaryl-2(5h)-fuaranone als cox-2-inhibitoren
US5691374A (en) 1995-05-18 1997-11-25 Merck Frosst Canada Inc. Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
US5756529A (en) 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
GB9520584D0 (en) 1995-10-09 1995-12-13 Fujisawa Pharmaceutical Co Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
UA57002C2 (uk) 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
EP0904269B1 (en) 1995-10-30 2002-01-23 Merck Frosst Canada & Co. 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
IL149581A0 (en) 1999-12-03 2002-11-10 Pfizer Prod Inc Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
TR200302047T4 (tr) 1999-12-03 2004-01-21 Pfizer Products Inc. Anti-iltihabik / analjezik maddeler olarak heteroaril fenil pirazol bileşikleri.
DE60004001T2 (de) 1999-12-03 2004-04-15 Pfizer Products Inc., Groton Acetylenderivate zur Verwendung als schmerzstillendes oder entzündungshemmendes Mittel

Also Published As

Publication number Publication date
MXPA04002879A (es) 2004-07-15
HUP0401914A3 (en) 2006-04-28
PA8555601A1 (es) 2003-09-17
US6846930B2 (en) 2005-01-25
GT200200183A (es) 2003-05-23
PL370110A1 (en) 2005-05-16
US20030100765A1 (en) 2003-05-29
WO2003029244A8 (en) 2003-09-04
PE20030532A1 (es) 2003-06-18
WO2003029244A1 (en) 2003-04-10
US20040044042A1 (en) 2004-03-04
AR036680A1 (es) 2004-09-29
UY27453A1 (es) 2003-04-30
RU2004109148A (ru) 2005-08-20
EP1430046A1 (en) 2004-06-23
US6646128B2 (en) 2003-11-11
JP2005504127A (ja) 2005-02-10
CN1561339A (zh) 2005-01-05
CZ2004414A3 (cs) 2004-12-15
ZA200401043B (en) 2005-04-15
IL160369A0 (en) 2004-07-25
CA2457798A1 (en) 2003-04-10
KR20040039424A (ko) 2004-05-10
BR0212860A (pt) 2004-10-13

Similar Documents

Publication Publication Date Title
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
AU2002327747A1 (en) Substituted pentacene semiconductors
HUP0300350A2 (hu) Új 3-amino-azetidin-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
MXPA02011370A (es) Iminoazinas substituidas.
MXPA04002067A (es) Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento.
HUP0402235A2 (hu) 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
SG161302A1 (en) DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE ss2 ADRENERGIC RECEPTOR
HUP0103433A2 (hu) Új izoxazolinon antibakteriális szerek, alkalmazásuk és eljárás vegyületek előállítására
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
HUP0204395A2 (hu) Új eljárás latanoproszt előállítására
TW200635939A (en) Tantalum compound, method for producing the same, tantalum-containing thin film and method for forming the same
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
HUP0201357A2 (hu) Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
HUP9800085A2 (hu) Eljárás karbonilvegyületek redukálására és alfa-amino-alkohol-származékok előállítására
HUP0203538A2 (hu) Új (4-hidroxi-bifenil)-hidrazid-származékok
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
HUP0401914A2 (hu) Eljárás piridil-alkilszulfonilpirazol-származékok előállítására
MXPA06000038A (es) Pirimidinas 2-sustituidas.
CA2221946A1 (en) Production process of cyclic compound
HUP9801056A2 (hu) Apolipoprotein-B szintézist gátló triazolonszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0402544A2 (hu) Kompozíció elektrolit oldathoz és eljárás az előállítására
MY129575A (en) Methods, kits and compositions for using pyrrole derivatives againts anxiety
HUP0402224A2 (hu) Helyettesített tetraciklusos tetrahidrofurán-származékok új mandelátsói
AU2003273675A1 (en) Protein tyrosine kinase inhibitors

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees